Dennis Klinman
54Patents
19h-index
21Co-inventors
84Inventor score
Filing activity: Feb 7, 1995 → Jul 8, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6207646A | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 467 | Expired |
| US6194388A | Immunomodulatory oligonucleotides | Chemistry; Metallurgy | 329 | Expired |
| US6977245B2 | Oligodeoxynucleotide and its use to induce an immune response | Emerging Cross-Sectional Technologies | 57 | Expired |
| US8058249B2 | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 35 | Expired |
| US7354909B2 | Method for rapid generation of mature dendritic cells | Chemistry; Metallurgy | 34 | Expired |
| US7723500B2 | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 33 | Active |
| US7713529B2 | Methods for treating and preventing infectious disease | Emerging Cross-Sectional Technologies | 33 | Expired |
| US7723022B2 | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 32 | Active |
| US8008266B2 | Methods of treating cancer using immunostimulatory oligonucleotides | Emerging Cross-Sectional Technologies | 30 | Expired |
| US7674777B2 | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 30 | Expired |
| US7521063B2 | Multiple CPG oligodeoxynucleotides and their use to induce an immune response | Emerging Cross-Sectional Technologies | 28 | Expired |
| US7879810B2 | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 27 | Active |
| US7666674B2 | Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo | Emerging Cross-Sectional Technologies | 25 | Expired |
| US7514414B2 | Suppressors of CpG oligonucleotides and methods of use | Chemistry; Metallurgy | 22 | Expired |
| US7514415B2 | Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides | Chemistry; Metallurgy | 21 | Expired |
| US7615227B2 | Use of CpG oligodeoxynucleotides to induce angiogenesis | Human Necessities | 21 | Expired |
| US8053422B2 | Anti-cancer oligodeoxynucleotides | Human Necessities | 19 | Active |
| US7959934B2 | Method for rapid generation of mature dendritic cells | Chemistry; Metallurgy | 19 | Active |
| US8043622B2 | Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides | Chemistry; Metallurgy | 19 | Expired |
| US7951786B2 | Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides | Chemistry; Metallurgy | 18 | Active |
| US7935351B2 | Use of CPG oligodeoxynucleotides to induce angiogenesis | Human Necessities | 17 | Active |
| US8158592B2 | Immunostimulatory nucleic acid molecules | Emerging Cross-Sectional Technologies | 17 | Active |
| US8030285B2 | Oligodeoxynucleotide and its use to induce an immune response | Emerging Cross-Sectional Technologies | 16 | Active |
| US8114848B2 | Immunomodulatory oligonucleotides | Human Necessities | 15 | Expired |
| US7758876B2 | Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides | Emerging Cross-Sectional Technologies | 15 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.